Email This Article
FDA Wants More Data From Celgene
By
Althea Chang
11/15/05 - 12:53 PM EST
The company wants to get Thalomid approved for treating blood cancer.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,394.11 | 1,104.56 | 2,189.05 | 34.52 |
Oil *
76.47
|
|
UP
5.21
|
DOWN
1.42
|
DOWN
5.30
|
DOWN
0.31
|
10 Yr
3.45%
SPDR Gold
113.42
|
|
+0.05%
|
-0.13%
|
-0.24%
|
-0.89%
|
Data delayed 20 minutes |


Connect with TheStreet